Advisory Board
The Editorial Advisory Board of Pharma Focus Asia comprises of industry thought leaders with wide-ranging experience, expertise and significant contributions to the pharmaceutical industry. We thank and acknowledge our Editorial Advisory Board members' willingness to share their expertise and industry insights with us to offer our readers the most appropriate editorials covering issues of paramount importance to the industry.
Imedla Leslie Rillon
Imelda Leslie Rillon has over twenty years of experience in quality management. Leslie is currently the Principal Consultant, Scendea.
Andri Kusandri
Andri Kusandri, is Market Access and Government & Public Affairs Director of Merck Indonesia in the last 7 years. Having obtained his Bachelor Degree in Pharmacy at the Institut Teknologi Bandung (ITB), he has spent the last 20 years with predominantly international pharmaceutical companies with UCB Pharma, Johnson & Johnson, Pfizer and currently work at Merck Indonesia. Andri has much experience in the field of Marketing, Market Access, Pricing, Government Affairs and Public Policy.
Hassan Mostafa Mohamed
Pharmaceutical, Biotechnology, and Healthcare: General Manager, Chief Quality Officer, Technical and Quality Director, Senior Quality Director, TQM Director, Professional and Expert Consultant, Proficient and Expert Trainer, Professional Lead Auditor, Expert Consultant @ MENA.
Nicoleta Grecu
Nicoleta Grecu has over 13 years of experience in the pharmaceutical industry with a broad expertise in human medicinal products, combination products, biologics, and vaccines. She is currently the Quality Management Consultant, GCP/GVP Compliance, Merck Healthcare.
Alessio Piccoli
Alessio Piccoli is Chief Commercial Officer (CCO), PI Health Sciences. He has over twenty years of experience across the pharmaceuticals, biotechnology, and CDMO/CMO sectors. Prior to joining Aragen, he has held senior positions at GSK, Aptuit, Sumitomo Corporation, Mitsubishi Chemical, AMRI, and SK Biotek.
Pramod Kashid
Pramod Kashid has more than 17 years’ experience in the clinical research industry. Dr Kashid is currently a Chief Executive Officer, Expecto Health Science. He has experience in leading clinical drug development projects in Oncology, Cardiology, and infectious disease therapeutic areas in Asia Pacific region. He has expertise in strategic drug development planning and cross-functional stakeholder management, audit, and inspection management.
Neil J Campbell
Neil J Campbell is currently Chairman and CEO for Mosaigen™, Inc., a global Life Science development corporation, located in Rockville, Maryland and Partner with Endeavour Capital in Asia. During his career, he has successfully developed and introduced over 200 products in healthcare, life sciences and information technology. He earned his MBA and MA in Management Systems from Webster University in Saint Louis, Missouri and his BS-BA from Norwich University in New England.
